FDA recommends guidance Revision Over Dialysis System Tubing Concern
Episode Summary
The Food and Drug Administration updated Prismaflex guidance highlights tubing-related risks, urging vigilance to prevent air-in-blood events and ensure safe, uninterrupted renal replacement therapy in critical care settings.